Presentations and Posters
2010
A multicenter, randomized phase II study of neoadjuvant chemotherapy including trastuzumab with cyclophosphamide with docetaxel in patients with operable HER2-positive breast cancer (JBCRG-10 study)
Norikazu Masuda, Masakazu Toi, Takayuki Ueno, Kenjiro Aogi, Hiroji Iwata, Shinji Ohno, Katsumasa Kuroi, Nobuaoki Sato, Seigo Nakamura : Japan Breast Cancer Research Group (JBCRG)
2010 American Society of Clinical Oncology, Chicago (USA), Jun. 2010
by Voluntary Organization JBCRG